{"text": ["FDA", "Oks", "Tafinlar", "+", "Mekinist", "For", "Adjuvant", "Treatment", "Of", "BRAF", "V600-mutant", "Melanoma"], "created_at": "2018-04-30 21:20:00"}
{"text": ["FDA", "Oks", "Tafinlar", "+", "Mekinist", "For", "Adjuvant", "Treatment", "Of", "BRAF", "V600-mutant", "Melanoma"], "created_at": "2018-04-30 21:20:00"}
{"text": ["Teva:", "\u2018Hold\u2019", "Ratings", "from", "55%", "of", "Analysts", "before", "1Q18", "Results"], "created_at": "2018-04-30 19:25:02"}
{"text": ["Analysts", "Raise", "Teva\u2019s", "Earnings", "Estimates", "before", "Its", "1Q18", "Results"], "created_at": "2018-04-30 17:55:02"}
{"text": ["Could", "Teva", "Exceed", "Analysts\u2019", "Sales", "Estimates", "for", "1Q18?"], "created_at": "2018-04-30 16:22:18"}
{"text": ["GlaxoSmithKline\u2019s", "1Q18", "Earnings:", "Consumer", "Healthcare", "Business"], "created_at": "2018-04-30 14:31:33"}
{"text": ["The", "Swiss", "Stock", "Market", "Climbed", "On", "Roche", "Strength"], "created_at": "2018-04-30 12:23:00"}
{"text": ["The", "Swiss", "Stock", "Market", "Climbed", "On", "Roche", "Strength"], "created_at": "2018-04-30 12:23:00"}
